rethinkPeptides Search
Menu
Research citation

Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.

Expert opinion on biological therapy, 23(8), 727-735

Citation

Zhang, Qin; Sun, Cheng; Wu, Jinying; Wu, Juan; Zhang, Xuan; Liu, Yueyue; Dou, Changlin; Qin, Huilin; Zhang, Qian; Zhou, Renpeng; Hu, Wei. (2023). Pharmacokinetic similarity study comparing the biosimilar candidate, LY05008, with its reference product dulaglutide in healthy Chinese male subjects.. Expert opinion on biological therapy, 23(8), 727-735. https://doi.org/10.1080/14712598.2023.2189009